Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 3
1987 5
1988 3
1989 2
1990 1
1992 3
1993 2
1994 10
1995 5
1996 5
1997 3
1998 4
1999 7
2000 3
2001 3
2002 7
2003 7
2004 3
2005 1
2006 6
2007 3
2008 4
2009 4
2010 6
2011 5
2012 2
2013 4
2014 5
2015 3
2016 2
2017 13
2018 5
2019 9
2020 6
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

157 results
Results by year
Filters applied: . Clear all
Page 1
Canine leishmaniasis.
Alvar J, Cañavate C, Molina R, Moreno J, Nieto J. Alvar J, et al. Adv Parasitol. 2004;57:1-88. doi: 10.1016/S0065-308X(04)57001-X. Adv Parasitol. 2004. PMID: 15504537 Review.
Leishmaniasis worldwide and global estimates of its incidence.
Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO Leishmaniasis Control Team. Alvar J, et al. PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31. PLoS One. 2012. PMID: 22693548 Free PMC article.
Leishmaniasis impact and treatment access.
den Boer M, Argaw D, Jannin J, Alvar J. den Boer M, et al. Among authors: alvar j. Clin Microbiol Infect. 2011 Oct;17(10):1471-7. doi: 10.1111/j.1469-0691.2011.03635.x. Clin Microbiol Infect. 2011. PMID: 21933305 Free article. Review.
Case study for a vaccine against leishmaniasis.
Alvar J, Croft SL, Kaye P, Khamesipour A, Sundar S, Reed SG. Alvar J, et al. Vaccine. 2013 Apr 18;31 Suppl 2:B244-9. doi: 10.1016/j.vaccine.2012.11.080. Vaccine. 2013. PMID: 23598489 Review.
Visceral leishmaniasis: elimination with existing interventions.
Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J. Matlashewski G, et al. Among authors: alvar j. Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Lancet Infect Dis. 2011. PMID: 21453873 Review.
Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.
Alves F, Bilbe G, Blesson S, Goyal V, Monnerat S, Mowbray C, Muthoni Ouattara G, Pécoul B, Rijal S, Rode J, Solomos A, Strub-Wourgaft N, Wasunna M, Wells S, Zijlstra EE, Arana B, Alvar J. Alves F, et al. Among authors: alvar j. Clin Microbiol Rev. 2018 Aug 29;31(4):e00048-18. doi: 10.1128/CMR.00048-18. Print 2018 Oct. Clin Microbiol Rev. 2018. PMID: 30158301 Free PMC article. Review.
Nutritional supplements for patients being treated for active visceral leishmaniasis.
Custodio E, López-Alcalde J, Herrero M, Bouza C, Jimenez C, Storcksdieck Genannt Bonsmann S, Mouratidou T, López-Cuadrado T, Benito A, Alvar J. Custodio E, et al. Among authors: alvar j. Cochrane Database Syst Rev. 2018 Mar 26;3(3):CD012261. doi: 10.1002/14651858.CD012261.pub2. Cochrane Database Syst Rev. 2018. PMID: 29578237 Free PMC article. Review.
Control of visceral leishmaniasis in East Africa: fragile progress, new threats.
Dahl EH, Hamdan HM, Mabrouk L, Matendechero SH, Mengistie TB, Elhag MS, Lado M, Adera C, Atia AA, Potet J, den Boer M, Ritmeijer K, Alvar J, Alves F, Alcoba G. Dahl EH, et al. Among authors: alvar j. BMJ Glob Health. 2021 Aug;6(8):e006835. doi: 10.1136/bmjgh-2021-006835. BMJ Glob Health. 2021. PMID: 34413075 Free PMC article. No abstract available.
Combination therapy for visceral leishmaniasis.
van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, Boelaert M. van Griensven J, et al. Among authors: alvar j. Lancet Infect Dis. 2010 Mar;10(3):184-94. doi: 10.1016/S1473-3099(10)70011-6. Lancet Infect Dis. 2010. PMID: 20185097 Review.
Leishmania/HIV co-infections in the second decade.
Cruz I, Nieto J, Moreno J, Cañavate C, Desjeux P, Alvar J. Cruz I, et al. Among authors: alvar j. Indian J Med Res. 2006 Mar;123(3):357-88. Indian J Med Res. 2006. PMID: 16778317 Free article. Review.
157 results